Holen Sie sich die Stockscreener-App
20.36
0.56%
-0.1461
Schlusskurs vom Vortag:
$20.51
Offen:
$20.48
24-Stunden-Volumen:
324.45K
Relative Volume:
0.06
Marktkapitalisierung:
$14.04B
Einnahmen:
$2.87B
Nettoeinkommen (Verlust:
$250.10M
KGV:
63.88
EPS:
0.3188
Netto-Cashflow:
$1.13B
1W Leistung:
-3.02%
1M Leistung:
-4.74%
6M Leistung:
+17.08%
1J Leistung:
+12.93%
1-Tages-Spanne:
$20.36
$20.57
1-Wochen-Bereich:
$20.39
$21.28
52-Wochen-Spanne:
$15.70
$22.95
Healthpeak Properties Inc Stock (DOC) Company Profile
Firmenname
Healthpeak Properties Inc
Sektor
Telefon
949-407-0700
Adresse
4600 SOUTH SYRACUSE STREET, DENVER, WI
Compare DOC vs WELL, VTR, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOC
Healthpeak Properties Inc
|
20.36 | 14.14B | 2.87B | 250.10M | 1.13B | 0.3188 |
WELL
Welltower Inc
|
236.20 | 170.96B | 11.75B | 1.46B | 2.19B | -0.6014 |
VTR
Ventas Inc
|
89.30 | 46.10B | 6.13B | 272.21M | 1.38B | 0.5521 |
OHI
Omega Healthcare Investors Inc
|
46.69 | 14.25B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
54.16 | 11.90B | 2.37B | 101.67M | 169.19M | 0.5775 |
Healthpeak Properties Inc Stock (DOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Eingeleitet | UBS | Neutral |
| 2026-02-05 | Herabstufung | Argus | Buy → Hold |
| 2026-01-09 | Eingeleitet | Goldman | Neutral |
| 2025-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-09-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-08-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-07-29 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-01-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-10-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-05-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-04-26 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-04-22 | Fortgesetzt | Mizuho | Buy |
| 2024-04-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-03-25 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-03-08 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2024-01-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-05 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-19 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-04-26 | Eingeleitet | Barclays | Overweight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-07 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2021-09-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-20 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-03-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2020-12-14 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-11 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-30 | Fortgesetzt | Robert W. Baird | Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Buy |
| 2020-04-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-01 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-03-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-02-27 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2019-12-20 | Eingeleitet | Mizuho | Buy |
| 2019-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-11-26 | Hochstufung | Stifel | Hold → Buy |
| 2019-10-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-06-20 | Eingeleitet | Citigroup | Neutral |
| 2019-05-02 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2018-08-03 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2018-04-25 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-01-05 | Bestätigt | Robert W. Baird | Outperform |
| 2017-11-06 | Hochstufung | Hilliard Lyons | Long-term Buy → Buy |
Alle ansehen
Healthpeak Properties Inc Aktie (DOC) Neueste Nachrichten
Healthpeak Properties Inc. stock underperforms Friday when compared to competitors - MarketWatch
HCP Changes Name to Healthpeak Properties - Nareit
Why Is Healthpeak (DOC) Down 3.5% Since Last Earnings Report? - Yahoo Finance
Healthpeak Properties Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Healthpeak Properties, Inc. (NYSE: DOC) President and CEO Scott Brinker Interviewed by Advisor Access - The Manila Times
Healthpeak Properties stock trades below target as 2026 guidance firms up - AD HOC NEWS
Barclays Adjusts PT on Healthpeak Properties to $24 From $23, Keeps Equalweight Rating - marketscreener.com
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - marketwatch.com
Medical Office Provides Steady Growth While Healthpeak's Life Science Portfolio Recovers - Morningstar
Healthpeak Properties Inc. stock underperforms Thursday when compared to competitors - MarketWatch
BofA Securities Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $25 - moomoo.com
Healthpeak Properties Inc. stock outperforms competitors on strong trading day - MarketWatch
Enterprise value to EBIT forward of Healthpeak Properties, Inc. – NYSE:DOC - TradingView
Healthpeak Properties Earnings: Signs of Life Science's Continued Recovery Despite NOI Decline - Morningstar
Healthpeak Properties Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Healthpeak (DOC) Price: Advances 1.44% to $20.73 at the Close; Level Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Available RecordInside Day Breakout - Vinanet
Healthpeak (DOC) Financial Results: Profit Per Share Clears Its Benchmark; Closing Reaction: The Market Price Declines 0.68% in the Latest ReadingPre-Earnings Setup - Vinanet
J.P. Morgan Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $22 - Moomoo
DOC Q2 2026 Earnings: EPS Beats Estimates by 143.9% as Stock SlipsDiluted EPS Report - Vinanet
Healthpeak Properties Inc's Dividend Analysis - GuruFocus
Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields - Benzinga
Russell Investments Group Ltd. Has $91.42 Million Stock Holdings in Healthpeak Properties, Inc. $DOC - MarketBeat
KBC Group NV Cuts Stake in Healthpeak Properties, Inc. $DOC - MarketBeat
NewEdge Advisors LLC Boosts Holdings in Healthpeak Properties, Inc. $DOC - MarketBeat
How Investors May Respond To Healthpeak Properties (DOC) Strong Q2 Results and Raised 2026 EPS Guidance - simplywall.st
Principal Financial Group Inc. Sells 2,005,068 Shares of Healthpeak Properties, Inc. $DOC - MarketBeat
TD Asset Management Inc Lowers Holdings in Healthpeak Properties, Inc. $DOC - MarketBeat
Massachusetts Financial Services Co. MA Purchases 2,883,382 Shares of Healthpeak Properties, Inc. $DOC - MarketBeat
Healthpeak Properties, Inc. $DOC Shares Sold by Oppenheimer Asset Management Inc. - MarketBeat
Healthpeak Properties, Inc. $DOC Holdings Lifted by Vontobel Holding Ltd. - MarketBeat
Healthpeak Properties, Inc. $DOC Shares Purchased by Chilton Capital Management LLC - marketbeat.com
Handelsbanken Fonder AB Boosts Stock Position in Healthpeak Properties, Inc. $DOC - marketbeat.com
Healthpeak Properties (NYSE:DOC): Is the Valuation Story Shifting? - Kalkine Media
Healthpeak Properties (NYSE:DOC): What Changes Next? - Kalkine Media
Healthpeak Properties (NYSE:DOC) Given New $24.00 Price Target at Robert W. Baird - MarketBeat
DOC Maintained by Baird -- Price Target Raised to $24.00 - GuruFocus
Baird Adjusts Price Target on Healthpeak Properties to $24 From $21, Keeps Outperform Rating - marketscreener.com
Healthpeak Properties (DOC) Q2 2026 Earnings Call Transcript - AOL.com
DOC Maintains by Citigroup -- Price Target Raised to $22.00 - GuruFocus
Healthpeak Properties Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Healthpeak Properties (NYSE:DOC): What Is Driving Fresh Attention? - kalkinemedia.com
Citigroup Adjusts Price Target on Healthpeak Properties to $22 From $20, Keeps Neutral Rating - marketscreener.com
BNP Paribas Adjusts Price Target on Healthpeak Properties to $23 From $22, Keeps Outperform Rating - marketscreener.com
Healthpeak Properties (DOC) Dips 1.27% to $20.64 as Healthcare REIT Consolidates Below ResistanceWyckoff Spring - dars.gov.et
Healthpeak Properties, Inc. (NYSE:DOC) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Should Healthpeak’s Stronger Q2 Earnings and Higher 2026 EPS Guidance Require Action From DOC Investors? - webull.com
Is the Options Market Predicting a Spike in Healthpeak Properties Stock? - Zacks Investment Research
DOC Maintained by RBC Capital -- Price Target Raised to $24.00 - GuruFocus
Royal Bank Of Canada Issues Positive Forecast for Healthpeak Properties (NYSE:DOC) Stock Price - MarketBeat
RBC Capital Adjusts PT on Healthpeak Properties to $24 From $21, Keeps Outperform Rating - marketscreener.com
Enterprise value to EBIT forward of Healthpeak Properties, Inc. – HAM:HC5 - TradingView
Finanzdaten der Healthpeak Properties Inc-Aktie (DOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.09%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):